StonvexLoading…
StonvexStonvexStonvexCore line items from NOC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $41.95B | $41.03B | $39.29B | $36.60B |
Operating Income | $4.51B | $4.37B | $2.54B | $3.60B |
Net Income | $4.18B | $4.17B | $2.06B | $4.90B |
EPS (Diluted) | $29.08 | $28.34 | $13.53 | $31.47 |
Total Assets | $51.38B | $49.36B | $46.54B | $43.76B |
Total Liabilities | $34.70B | $34.07B | $31.75B | $28.44B |
Cash & Equivalents | $4.40B | $4.35B | $3.11B | $2.58B |
Free Cash Flow OCF − CapEx | $3.31B | $2.62B | $2.10B | $1.47B |
Shares Outstanding | 142.00M | 144.95M | 150.11M | 153.16M |